Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia

Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia

Background<br /> There is limited evidence detailing the cost-effectiveness of psoriasis treatments in the Asian region. Therefore, this study is aimed to evaluate the cost-effectiveness of 3 psoriasis treatments tailored for moderate to severe psoriasis, namely topical and phototherapy (TP),...

Full description

Bibliographic Details
Main Authors:	Nor Azmaniza Azizam, Aniza Ismail, Saperi Sulong, Norazirah Md Nor
Format:	Article
Language:	English
Published:	Kerman University of Medical Sciences 2019-07-01
Series:	International Journal of Health Policy and Management
Subjects:	cost-effectiveness psoriasis phototherapy systemic biologic malaysia
Online Access:	https://www.ijhpm.com/article_3607_0ff4b5f866b1c8a515c725f7d36992cd.pdf

Similar Items

Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects
by: Franken SM, et al.
Published: (2016-05-01)

Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey
by: April W. Armstrong, et al.
Published: (2024-01-01)

Tazarotene gel with narrow-band UVB phototherapy: a synergistic combination in psoriasis
by: Surabhi Dayal, et al.
Published: (2018-06-01)

Cost analysis of psoriasis treatment modalities in Malaysian public hospitals
by: Azizam NA,, et al.
Published: (2019)

Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
by: Jashin J. Wu, et al.
Published: (2018-11-01)

Treatment of psoriasis vulgaris: guidelines of experts of the Polish Dermatological Society. Part II: moderate to severe psoriasis
by: Jacek Szepietowski, et al.
Published: (2014-11-01)

Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis
by: Jashin J. Wu, et al.
Published: (2021-10-01)

Impact of Comorbidities of Patients with Psoriasis on Phototherapy Responses
by: Belén Fatás-Lalana, et al.
Published: (2022-08-01)

Psoriasis Treatment by Using Narrowband-UVB Phototherapy
by: Layth M. Karim, et al.
Published: (2022-03-01)

Dermoscopy as a prognostic tool for the therapeutic response of phototherapy and methotrexate in psoriasis
by: Shaimaa I Omar, et al.
Published: (2020-01-01)

The effect of biological agents on antinuclear antibody status in patients with psoriasis: A single-center study
by: Ömer Kutlu, et al.
Published: (2020-01-01)

Psoriasis part 2 – topical treatment, phototherapy and skin care
by: Ewa Zwierzyńska, et al.
Published: (2023-12-01)

Effciency of narrowband medium wave (UVB) phototherapy in combination with cytostatic therapy in psoriasis
by: Rasskazov Y.A, et al.
Published: (2012-06-01)

Psoriasis in children
by: Pinson R, et al.
Published: (2016-10-01)

Effciency and safety of the use of long-wave UVA-1 phototherapy in treatment of psoriasis
by: Bakulev A.L., et al.
Published: (2012-06-01)

Treatment of Plaque Psoriasis by 308 nm Excimer Light in Egyptian Patients
by: Essameldin M Mohamed, et al.
Published: (2018-03-01)

Evaluation of neopterin level and disease severity in patients with psoriasis vulgaris treated with narrowband UVB
by: Funda Kemeriz, et al.
Published: (2019-01-01)

Psoriasis on Lesions of Vitiligo: A Case Report
by: Wang L, et al.
Published: (2023-08-01)

SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
by: L. S. Namazova-Baranova, et al.
Published: (2017-10-01)

Eficacia terapéutica con el método de Goeckerman en pacientes con psoriasis en placas: Trabajo realizado en el servicio de dermatología del Hospital Carlos Andrade Marín (Ecuador) Agosto-Noviembre de 2001 Therapeutic efficacy of Goeckerman's method in patients with plaque psoriasis
by: L M Dressendörfer, et al.
Published: (2006-12-01)

Efficacy of narrowband phototherapy in the treatment of different forms of psoriasis with the predominant affection of palms and soles
by: Marina A. Gureeva, et al.
Published: (2021-12-01)

Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective
by: Riley K. Spencer, et al.
Published: (2023-03-01)

Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia
by: Yazed AlRuthia, et al.
Published: (2023-12-01)

Recommendations for management of childhood psoriasis
by: Bhumesh Kumar Katakam, et al.
Published: (2021-01-01)

Effective use of oral tofacitinib and phototherapy in a patient with concomitant alopecia areata, vitiligo, and plaque and inverse psoriasis
by: Mahroo Tajalli, et al.
Published: (2020-05-01)

Monochromatic excimer light in south indian patients (Skin type IV, V, and VI) with palmoplantar psoriasis: A case series
by: Saritha Mohanan, et al.
Published: (2023-01-01)

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
by: Jinsui Zhang, et al.
Published: (2023-09-01)

A Randomized Controlled Trial with a Medical Device Containing Sodium Hyaluronate and Nicotinic Acid to Increase the Efficacy of Ultraviolet Phototherapy in Psoriasis
by: Balázs Bende, et al.
Published: (2020-05-01)

Narrowband Ultraviolet B (NB-UVB) Phototherapy in Psoriasis: A Retrospective Study
by: Faida Ufaira Prameswari, et al.
Published: (2022-07-01)

Tissue lipocalin-2 in psoriasis: is it a marker of metabolic disturbance or a possible marker of therapeutic efficacy after narrow band ultraviolet B?
by: Rania Abdel Hay, et al.
Published: (2020-07-01)

Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany
by: Matthias Augustin, et al.
Published: (2022-02-01)

Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States
by: Xiaoying Jia, et al.
Published: (2022-02-01)

Erythema Increase Predicts Psoriasis Improvement after Phototherapy
by: Trinidad Montero-Vilchez, et al.
Published: (2021-08-01)

Effect of narrow-band ultraviolet B phototherapy, methotrexate, and combined narrow-band ultraviolet B phototherapy with methotrexate on serum cathelicidin and vitamin D in patients with psoriasis vulgaris
by: Mohammed Abu El-Hamd, et al.
Published: (2022-01-01)

A Priori Estimation of the Narrow-Band UVB Phototherapy Outcome for Moderate-to-Severe Psoriasis Based on the Patients’ Questionnaire and Blood Tests Using Random Forest Classifier
by: Narbutt J, et al.
Published: (2021-03-01)

Institute for clinical and economic review (ICER) psoriasis update 2018: what it means for dermatologists treating moderate-to-severe plaque psoriasis
by: Erica B. Lee, et al.
Published: (2019-11-01)

Ultrasructural organization of inflammatory infiltrate’s cells in skin of patients with psoriasis treated by NB-UVB (311 nm)
by: Babanin V.A., et al.
Published: (2013-01-01)

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies
by: Edoardo Mortato, et al.
Published: (2023-06-01)

Effect of Narrow-Band Ultraviolet B Therapy of Psoriasis Vulgaris on Skin Directional Reflectance, Skin Density and Epidermal Thickness
by: Wiktoria Odrzywołek, et al.
Published: (2023-08-01)

Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan
by: April W. Armstrong, et al.
Published: (2017-10-01)